Mark, an acclaimed litigator who leads McGuireWoods’ national trial team, represents clients in their most challenging matters in courts across the country. Throughout his 30-year career, he has prepared hundreds of complicated cases for trial and has served as lead appellate counsel in dozens of reported decisions. Mark’s trial practice remains very active as reflected by the 26 trial weeks he has spent as lead counsel for seven jury trials in six different jurisdictions over the past two years.
His work in high-profile matters across industries has earned him inductions into the American College of Trial Lawyers, the International Academy of Trial Lawyers and the American Board of Trial Advocates.
As a trial lawyer, Mark has brought a range of complex cases to jury verdict. His varied client base includes both commercial entities and healthcare practitioners and institutions involved in litigation.
Mark began his career handling jury trials throughout North Carolina, mentored by some of the state’s finest trial lawyers. Originally focusing on the malpractice arena, he is now a general purpose trial lawyer handling a broad array of matters including product liability, commercial disputes, financial contracts, toxic torts, mass torts, insurance coverage, as well as fire and explosion.
In addition to his North Carolina license, Mark is a member of the New York State Bar. With client engagements becoming more national in scope, he works out of the firm’s Raleigh and New York offices.
An active member of his local community, Mark contributes a significant amount of his time to educational organizations. He is currently serving on the advisory board of The Feagin Leadership Program, the mission of which is to provide a transformational learning experience that develops effective, ethical leaders who positively influence healthcare. He has served two terms on the Board of Trustees of Durham Academy, the K-12 school attended by his four children. He also was a founding director of Durham Nativity School, an institution dedicated to educating middle-school boys from financially challenged families as well as Student U, a collaborative organization providing services for students from the summer before they enter sixth grade until their high school graduation.
Mark has been honored in multiple years by Chambers USA on its list of America's Leading Lawyers for Business, and Benchmark Litigation lists him as a Local Litigation Star. He has been recognized several times by Law & Politics as one of the Top 100 Attorneys in North Carolina and by Best Lawyers as Raleigh Lawyer of the Year for Professional Malpractice Law – Defendants and for Personal Injury Litigation - Defendants.
Representation of and serve as lead trial counsel for a major financial institution in defense of claims arising out of the World Trade Center collapse, pending in the Southern District of New York.
Serve as national trial counsel to a market leading medical device manufacturer.
Served as lead counsel in trial named by CVN as top ten defense verdict of 2015.
Representation of publicly traded company and board members in shareholder actions filed as a result of corporate merger agreements.
Tried to jury verdict in excess of 50 medical malpractice cases in defense of healthcare practitioners and institutions.
Serve as trial counsel to one of the nation’s largest packaged food companies in cases arising from a plant explosion.
Serve as lead counsel for academic medical center in litigation arising out of clinical trials.
Served as lead appellate counsel in excess of 35 reported decisions.
Fellow, American College of Trial Lawyers; Chair, Judiciary Committee; Member, ACTL Task Force on Boot Camp Trial Training Program; Member, North Carolina Committee
Fellow, International Academy of Trial Lawyers
Trustee, Durham Academy, 2006-2012
Member, American Bar Association
Member, Litigation Section; Board of Directors, 2008-2011; Past Chairman, Medical Malpractice Section; Co-chair, Legislative Committee, 2008-2009, North Carolina Association of Defense Attorneys
Member, American Board of Trial Advocates; National Board Member
Trustee and Founding Board Member, Durham Nativity School, 2001-2009
Fellow, American College of Trial Lawyers
Fellow, American Board of Trial Advocates
Fellow, International Academy of Trial Lawyers
Selected for inclusion in America's Leading Lawyers for Business, Litigation: Healthcare and Medical Malpractice, North Carolina, Chambers USA, 2012-2019
Named to "Leaders in the Law," North Carolina Lawyers Weekly, 2017
Selected for inclusion as a "Leading Lawyer," Product Liability, Mass Tort and Class Action: Toxic Tort - Defense, Legal 500 US, 2016-2017
Named to '2013 Top Rated Lawyers,' Health Care, American Lawyer Media and Martindale-Hubbell, 2013
Named a "Local Litigation Star," North Carolina, Benchmark Litigation, 2013
Named "Lawyer of the Year," Personal Injury Litigation - Defendants, Raleigh, Best Lawyers, 2018
Named "Lawyer of the Year," Professional Malpractice Law - Defendants, Raleigh, Best Lawyers, 2012, 2016-2017
Selected for inclusion in The Best Lawyers in America, Commercial Litigation, Medical Malpractice Law – Defendants, Personal Injury Litigation – Defendants, Professional Malpractice Law, Woodward/White, Inc., 2007-2018
Named to "North Carolina Super Lawyers,” Business Litigation, Personal Injury Defense: Medical Malpractice, Super Lawyers, Thomson Reuters, 2007-2019
Named to "Leaders in the Law," North Carolina Lawyers Weekly, 2011
Named to "Top 100 Attorneys in North Carolina," Law & Politics, 2008, 2014
Named to "Legal Elite," Litigation, Business North Carolina, 2006, 2007, 2009, 2010, 2013, 2014
Named "Triangle, Mover & Shaker," Business Leader Magazine, 2008
AV Rated, Martindale-Hubbell
Financial Times Names McGuireWoods Most Innovative Firm for Business of Law
December 12, 2018
Strategy Sessions: Trial Team Roundtables
October 27, 2018
McGuireWoods’ Mark Anderson Honored Among North Carolina’s Leaders in the Law
September 18, 2017
McGuireWoods Team Secures Favorable Outcome for Client Olympus in High-Profile Product Liability Trial Involving Medical Scopes
July 26, 2017